In the ventral nerve cord of the isopod Idotea emarginata, FMRFamide-immunoreactive efferent neurons are con®ned to pereion ganglion 5 where a single pair of these neurons was identi®ed. Each neuron projects an axon into the ipsilateral ventral and dorsal lateral nerves, which run through the entire animal. The immunoreactive axons form numerous varicosities on the ventral¯exor and dorsal extensor muscle ®bres, and in the pericardial organs. To analyse the neuromuscular effects of a FMRFamide, we used the DRNFLRFamide (DF 2 ). DF 2 acted both pre-and postsynaptically. On the presynaptic side, DF 2 increased transmitter release from neuromuscular endings. Postsynaptically, DF 2 depolarized muscle ®bres by approximately 10 mV. This effect was not observed in leg muscles of a crab. The depolarization required Ca 2 , was blocked by substituting Ca 2 with Co 2 , but not affected by nifedipine or amiloride. In Idotea, DF 2 also potentiated evoked extensor muscle contractions. The amplitude of high K contractures was increased in a dose dependent manner with an EC 50 value of 40 nM. In current-clamped ®bres, DF 2 strongly potentiated contractions evoked by current pulses exceeding excitation-contraction threshold. In voltage-clamped ®bres, the inward current through L-type Ca 2 channels was increased by the peptide. The observed physiological effects together with the localization of FMRFamide-immunoreactive efferent neurons suggest a role for this type of peptidergic modulation for the neuromuscular performance in Idotea. The pre-and postsynaptic effects of DF 2 act synergistically and, in vivo, all should increase the ef®cacy of motor input to muscles resulting in potentiation of contractions.
Introduction
Since the isolation of the tetrapeptide FMRFamide from the clam Macrocallista nimbosa (Price & Greenberg, 1977) , more than 100 different FMRFamide-related peptides (FaRPs) have been characterized. This high number makes members of this peptide family one of the most abundant modulators. They are present in the nervous system of all major invertebrate groups, particularly of arthropods (for summary, see Greenberg & Price, 1992; Orchard et al., 2001; Sithigorngul et al., 2002) , and have been found in all classes of vertebrates (for references see Oelschla Èger et al., 1998; Askwith et al., 2000) . FaRPs are involved in heterogeneous modulation in multiple targets. In arthropods, they exert excitatory and inhibitory effects on heartbeat, and on contractions of visceral and skeletal muscles (for summary in insects, see Orchard et al., 2001 ; in crustaceans, Tierney et al., 1997) . In addition to the peripheral effects on neuromuscular parameters, FaRPs also modulate activity in neuronal networks such as the crustacean stomatogastric central pattern generators (Weimann et al., 1993; Tierney et al., 1997; Jorge-Rivera et al., 1998) .
In crustaceans, 19 distinct FaRPs have been identi®ed so far (Marder et al., 1987; Trimmer et al., 1987; Krajniak, 1991; Mercier et al., 1993; Weimann et al., 1993; Sithigorngul et al., 1998 Sithigorngul et al., , 2001 Sithigorngul et al., , 2002 . They all share a common C-terminal sequence, the tetrapeptide XLRFamide (with X standing for F or R). The isolation and identi®cation of crustacean FaRPs have progressed much faster than the investigation of their physiological roles. Four of the peptides have been shown to increase transmitter release from neuromuscular endings in crab, cray®sh and lobster (Kravitz et al., 1980; Mercier et al., 1990 Mercier et al., , 1993 Krajniak, 1991; Pasztor & Golas, 1993; Skerrett et al., 1995; Worden et al., 1995; Jorge-Rivera & Marder, 1996; Friedrich et al., 1998; Rathmayer et al., 2002a) . For one of these, DRNFLRFamide (DF 2 ), it was recently demonstrated that the increase of transmitter release at crab neuromuscular terminals is mediated by selective axontype-speci®c modulation of presynaptic o-conotoxin-sensitive N-type Ca 2 channels (Rathmayer et al., 2002a) . In contrast to the wellstudied presynaptic effects, little is known about the postsynaptic mechanisms underlying the potentiation of muscle contraction by FaRPs. This investigation was the aim of the present study. In muscle ®bres of the isopod crustacean Idotea, the peptide induces depolarization accompanied by a decrease in input resistance. In addition, DF 2 increases the inward Ca 2 current that provides the Ca 2 required to activate contraction. These postsynaptic effects, together with a DF 2 induced presynaptic increase of transmitter release, imply a role of a FMRFamide-related peptide in muscle performance in Idotea. One in vivo-source for the peptide is a single pair of FMRFamide-immunoreactive neurons in the ventral nerve cord.
Materials and methods

Animals
Adult males of the marine isopod Idotea emarginata were used for all experiments. Specimens of 10 20 mm body length were obtained from the Marine Station at Helgoland (Germany) and reared at the Animals Facility of the University of Konstanz. Animals were kept in tanks with circulating arti®cial seawater (ASW, see below) under a 14-h light : 10-h dark cycle at 16 8C.
Immunohistochemistry
Immunohistochemical staining with a FMRFamide antiserum was performed on wholemount preparations of isolated ventral nerve cord and dorsal extensor muscles. Tissue dissection procedure was as follows. After anaesthetizing the animal by chilling, the head and the legs were removed. Specimens were pinned ventral side up in a Sylgard-coated dish. The pereion sternites with attached¯exor muscles and the ventral nerve cord were removed. The nerve cord comprising all pereion and pleon ganglia was isolated by cutting the segmental nerves. From the dorsal body half, the gut, gonads, and heart were removed to expose the extensor muscle ®bres with peripheral nerve branches attached. The staining procedure used for immunohistochemical identi®cation of FMRFamide-immunoreactive (FMRFa-ir) neurons, axons and their neuromuscular terminals followed that described previously (Kreissl et al., 1999) . Brie¯y, dorsal or ventral body halves and isolated nerve cords were ®xed in 4% paraformaldehyde in 0.1 M phosphate buffer at pH 7.4 for 2 4 h at 4 8C. After washing with phosphate buffered saline (PBS) containing 0.5% Triton X-100 (PBSX 0.5), the preparations were incubated in a 1 : 1000 solution of the primary antiserum (a-FMRFamide; DiaSorin, Stillwater, MN, USA) in PBSX 0.5 with 0.2% bovine serum albumin for 12 18 h at 4 8C. The tissue was rinsed with PBSX 0.1. Binding of the primary antiserum was visualized using a Cy3-conjugated goat antirabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). The secondary antiserum was applied at a dilution of 1 : 600 in PBSX 0.5 for at least 6 h. After ®nal washes in PBS, preparations were dehydrated, mounted in 90% glycerol and examined with a Zeiss uorescence microscope.
Retrograde axonal staining and fluorescence double labelling
To identify FMRFa-ir neurons innervating the extensor muscle ®bres, retrograde ®lling with Lucifer Yellow (Molecular Probes, Eugene, OR, USA) was combined with immunostaining. Double labelling experiments were performed as described previously (Kreissl et al., 1999) . Back®lling nerves N3B, which supply the pereional extensor muscles, with a 3.5% solution of Lucifer Yellow achieved staining of efferent neurons within the pereion ganglia. Diffusion and retrograde transport of the dye were allowed to take place at room temperature for approximately 1 h. Isolated nerve cords were subsequently ®xed in 4% paraformaldehyde in 0.1 M phosphate buffer at pH 7.4 for 2 4 h. After washing with PBSX 0.5, preparations were dehydrated and mounted in glycerol. Ganglia were examined under uorescence before further immunostaining. Successfully ®lled Lucifer Yellow preparations were processed with the FMRFamide antiserum as described above.
The preparations were examined with a Zeiss Axiovert 35¯uores-cence microscope using appropriate ®lter combinations. Photographs were taken with a conventional camera and subsequently improved by digital processing using Photoshop 6.0 software (Adobe Systems Inc., San Jose, CA, USA) to obtain compound illustrations.
Electrophysiological techniques
For all experiments in Idotea, the individually identi®able extensor muscle ®bre 2 of pereion segment 7 was used (for anatomical details, see Kreissl et al., 1999) . To expose the extensor muscle, the preparation was pinned ventral side up in a Sylgard-coated dish. Pereion sternites with attached¯exor muscles and the ventral nerve cord were removed. Excitatory postsynaptic currents (EPSCs) were elicited focally by stimulating individual release boutons with depolarizing current pulses of 0.1 0.5 ms duration and 2 8 mA amplitude through a macropatch electrode (Zeitz Instruments, Augsburg, Germany; for details of recording from and stimulating of release boutons in Idotea, see Kreissl et al., 1999) . The macropatch electrodes had tip openings of approximately 10 mm diameter and a DC resistance of 0.1 0.3 MO. EPSCs were stored on a PC using a DigiData 1200 interface (Axon Instruments, Foster City, CA, USA) and pClamp acquisition software (Axon Instruments).
For electrophysiological experiments with the crab Eripha spini frons, ®bres of the closer muscle from walking legs were used. The preparation has been described in detail previously (Rathmayer & Erxleben, 1983) .
Intracellular recordings and current-/voltage-clamp measurements were performed using an AxoClamp 2B ampli®er (Axon Instruments). Pulse protocols and data acquisition were controlled with the help of pClamp 8.0 software (Axon Instruments). Conventional intracellular electrodes were ®lled with a 1 : 1 mixture of 3 M KCl and K citrate and had DC resistances between 1.5 and 5 MO. A grounded shield was placed between the two microelectrodes during the clamp experiments to reduce capacitative coupling. Current-clamp measurements were performed by intracellular injection of constant current pulses of 150 300 ms duration and increasing amplitude with the resulting voltage responses and associated contractions recorded simultaneously from the same ®bres. Details for using the two-electrode voltage clamp in muscle ®bres of Idotea and the quantitative analysis of the major membrane currents have been described recently (Weiss et al., 2001) . In brief, depolarization-activated membrane inward currents were recorded in two-electrode voltage-clamp conditions. Currents were elicited from a holding potential of À70 mV by short (100 200 ms) depolarizing voltage steps to potentials between À60 and 20 mV. Current records were digitized at 10 kHz, leak subtracted with a P/4 protocol and ®ltered at 3 kHz during acquisition. Data analysis was performed using pClamp 8.0 (Axon Instruments) and Origin 6.0 (Microcal Software, Inc., Northampton, MA, USA).
Contraction measurements
In preparations dissected as described above for electrophysiological recordings, the intersegmental membrane between pereion segment 6 and 7 was cut and pleon segment 1 was transected to yield an isolated preparation consisting of the dorsal half of pereion segment 7 only. The remaining parts of the long ®bres 5 and 6, which span two segments, were then removed. The cleaned preparation contained only the short ®bres 1 4, but in many experiments (e.g. high K contractures) ®bres 3 and 4 were cut to prevent them from contributing to force generation leaving only ®bre 2 and the thin ®bre 1 intact. The ®nal preparation was transferred into a small bath (300 mL volume) lined with Sylgard. The anterior rim of pereion segment 7 was ®xed with ®ne pins. The posterior end of the preparation was attached to a small metal pin connected to a force transducer for recording muscle tension (see below). Finally, the preparation was stretched to in situ resting length of the muscle ®bres. This tension was taken as zero tension in the contraction measurements. The bath was continuously perfused with cooled (18 8C) ASW at a¯ow rate of 0.5 2.5 mL/min. Substituted solutions and drugs were applied to the bath with the help of a switching port in the perfusion system. Brief contractions were evoked by intracellular injection of depolarizing current pulses. Prolonged contractions were induced by elevated extracellular potassium (high K contractures). Muscle tension was measured isometrically with a KG3 force transducer (Scienti®c Instruments Gu Èth, Heidelberg, Germany). Tension records were digitized at 10 kHz and low-pass ®ltered between 0.5 and 3 kHz with an eight-pole Bessel ®lter.
All numerical data are expressed as mean AE SEM. Statistical evaluation was performed applying a Student's t-test for paired data (Origin 6.0). P-values of less than 0.05 were considered to indicate a signi®cant difference between means.
Physiological solutions and chemicals
Arti®cial seawater (ASW) used as saline contained (in mM) 490 NaCl, 8 KCl, 10 CaCl 2 , 48 MgCl 2 , 30 D()-glucose and 20 HEPES buffer at pH 7.4. Co 2 -and Ba 2 -ASW were prepared by replacing CaCl 2 with CoCl 2 or BaCl 2 , respectively. In experiments where high K (20 100 mM) was used to induce muscle contractures, Na was substituted with equimolar K . Tetraethylammonium (TEA)/4-aminopyridine (4-AP)-ASW was made by substituting TEA (490 mM) for Na and adding 4-AP (10 mM) to the solution without substitution. BaCl 2 , CoCl 2 , TEA and 4-AP were obtained from Sigma (Deisenhofen, Germany). Other chemicals were purchased from Roth (Karlsruhe, Germany).
Amiloride (Sigma), used at a concentration of 10 mM, was diluted in ASW from a stock solution of 10 mM dissolved in distilled water. Nifedipine (Biotrend, Ko Èln, Germany) was made up in dimethyl sulfoxide before being dissolved in ASW to the desired concentration (50 mM), resulting in a DMSO concentration of 0.2% in the physiological solutions used in respective experiments. Control measurements revealed no observable effects of 0.2% DMSO alone on properties or responses of extensor muscle ®bres (Weiss et al., 2001) . Synthetic DF 2 with the amino acid sequence DRNFLRF-NH 2 was purchased from Sigma. The peptide was dissolved in distilled water at a concentration of 1 mM, lyophilized and stored at À30 8C. Stock solutions were aliquoted and diluted in ASW to the desired concentrations just prior to the experiments.
Results
FMRFamide-immunoreactivity in efferent neurons
Staining the ventral nervous system of Idotea with an antiserum against the tetrapeptide FMRFamide revealed in each of 22 preparations extensively ramifying axon processes in all seven pereion ganglia. A number of immunoreactive axons run through the connectives and traverse in a dorsal tract the entire ventral nerve cord. Some of the axons belong to FMRFamide-immunoreactive (FMRFa-ir) interneurons of small soma size, which are present in all ganglia. In addition to the small interneurons, a single pair of large FMRFa-ir neurons (soma diameter 30 35 mm) was consistently located anterolaterally in pereion ganglion 5 (peg 5, Fig. 1A and B, arrowheads). The axons of these two neurons exit peg 5 ipsilaterally through nerves N3 (Fig. 1A, ®lled arrow) . To verify that this pair of FMRFa-ir neurons is involved in the innervation of muscles, a double-staining procedure was employed using Lucifer Yellow back®lls (green) and FMRFamide immunohistochemistry (red). Of the 18 efferent neurons stained by unilateral back®lling of nerve N3B of peg 5 only one is located in the ipsilateral-anterolateral part of the ganglion (Fig. 1C, arrowhead) . This neuron is therefore unambiguously identi®able in all preparations. After treatment of ®ve successfully back®lled preparations with the FMRFamide-antiserum, double exposure showed that this cell body appeared yellow, indicating that it contained both¯uorescent markers (Fig. 1D, solid arrowhead) . The contralateral cell body lacking Lucifer Yellow stained only with the FMRFamide-antiserum (Fig. 1D, open arrowhead) . The two anterolateral cells in peg 5 are the only efferent neurons within the entire ventral nerve cord that are FMRFamide-immunoreactive. The axon of each FMRFa-ir neuron exits through N3 of pereion segment 5 (Pe 5) and, at the branching point of N3 in the next posterior segment (Pe 6), bifurcates and enters the two nerve branches N3A and N3B (Fig. 1A and E). The axon branch in N3A joins the ventral sinus nerve (Demassieux, 1979) and forms numerous varicose arborizations on most¯exor muscle ®bres in the entire pereion and the anterior two pleon segments. The abundance of FMRFa-ir varicosities is highest on exor muscle ®bres in segments Pe 7 to Pl 2 and decreases anteriorwards. In Pe 1, only the median muscle ®bres receive FMRFa-ir innervation. The FMRFa-ir axon branch in N3B of peg 5 also extends into N3Dv in Pe 6, which approaches the deep, i.e. ventral layer of the two-segmental ®bres of the extensor muscle. It projects into the dorsal lateral nerve (DLN) and divides into an anterior and a posterior branch ( Fig. 1E and G) . The anterior branch of the FMRFa-ir axon remains within the DLN and extends anteriorwards to the head without forming arborizations on the extensor muscle ®bres in segments Pe 1 to Pe 5 (Fig. 1G) . In these segments, the DLN runs longitudinally on the anterior parts of the two segmental muscle ®bres 5 (for details of anatomy see Kreissl et al., 1999) . The posterior branch gives rise to numerous FMRFa-ir arborizations in segments Pe 6 to Pl 2, which contribute to the dense meshwork of varicose axon endings within the pericardial organ (Fig. 1G) .
Effects of DF 2 on transmitter release
The localization of FMRFa-ir efferent neurons with axons projecting to¯exor and extensor muscles suggests a role for one or several members of this peptide family in the modulation of neuromuscular parameters. We have selected one member of this peptide family, the DRNFLRFamide DF 2 because it has been shown previously to occur in the nervous system of crustaceans and has been used in a number of studies in other crustacean preparations. DF 2 has been shown to increase the number of transmitter quanta released at neuromuscular endings in cray®sh and crab (Mercier et al., 1990 (Mercier et al., , 2002 Skerret et al., 1995; Rathmayer et al., 2002a) . In Idotea, application of DF 2 (500 nM) also increased the amplitude of excitatory postsynaptic currents (EPSCs) evoked by direct stimulation of individual release boutons on extensor muscle ®bres through a macropatch electrode ( Fig. 2A) . Figure 2B illustrates a typical experiment. The mean amplitude of the EPSCs in the controls (1.7 nA) was increased in the presence of the peptide to 2.1 nA. The average increase of the EPSC amplitudes was 14 AE 4% and statistically signi®cant (P 0.02, n 7, Fig. 2C ).
Effects of DF 2 on membrane potential and input resistance
The average membrane potential of the ®bres studied in this investigation was À72 AE 1 mV. In all experiments, application of 100 nM DF 2 signi®cantly depolarized the ®bres to an average value of À64 AE 1 mV (P 0.01, n 52). Although the peptide-induced depolarization of the muscle ®bres led to a small decrease in the amplitude of individual excitatory postsynaptic potentials due to a decrease in electrical driving force, the overall amplitude of membrane depolarizations achieved by junction potentials riding on top of the peptide-induced depolarization was always higher in the presence of the peptide (data not shown). The change in membrane potential by approximately 10 mV was almost completely reversed after washing in normal ASW. As illustrated in Fig. 3A , the DF 2 -induced depolarization was not affected by amiloride (10 mM, n 4), which has been shown to block FMRFamide-induced depolarization in molluscan neurons (Ruben et al., 1986) . In contrast, substitution of Ca 2 by Co 2 , which is an effective Ca 2 channel blocker in these muscles (Weiss et al., 2001) , abolished the peptide response completely (Fig. 3B) . Total inhibition of the DF 2 effect on membrane resting potential was observed in six preparations altogether, suggesting at least participation of Ca 2 in this depolarization. However, application of 50 mM nifedipine, an effective blocker of high-voltage-activated L-type Ca 2 channels in these ®bres (Erxleben & Rathmayer, 1997), was without effect (Fig. 3C, n 4) indicating that this type of Ca 2 channel is not involved in the effect. As the depolarization of muscles by DF 2 observed consistently in Idotea is in contrast to reports in other crustacean muscle preparations (for references see Discussion), we have looked into a different nervemuscle preparation, the closer muscle of the crab Eriphia spinifrons. In this preparation, DF 2 had no effect on membrane potential (n 5, data not shown).
To quantify the peptide-evoked increase in membrane conductance observed in muscles of Idotea, input resistance (R i ) was determined under two-electrode current-clamp conditions in control ASW and in the presence of the peptide. R i varied considerably in the controls and ranged from 73 to 764 kO with an average at 311 AE 38 kO (n 18) which is lower than that found in a previous study and probably due to seasonal effects (Weiss et al., 2001) . Figure 4A illustrates a typical peptide effect observed in a current-clamped ®bre. Application of 100 nM DF 2 reduced the amplitude of electrotonic potentials. R i , determined from the slope of the linear part of the I V curve (DV m AE 10 mV, Fig. 4B ) was decreased from 570 kO in the control to 341 kO in the presence of DF 2 . Similar results were obtained in another 17 preparations. Figure 4C summarizes the data. The average reduction of R i by the peptide was 17 AE 3% (P 0.001, n 18).
Potentiation of potassium contractures by DF 2
Application of saline solutions with elevated K in concentrations between 20 and 60 mM elicited graded slow depolarizations between 10 and 35 mV resulting in graded contractures of the muscle ®bres (Fig. 5A) . Membrane depolarization was linearly correlated with the K concentration in the bath. Generally, peak tension amplitude evoked by a given K concentration varied among preparations (Fig. 5B ). On average, it was 11 AE 4 mN at 20 mM (n 9), 102 AE 31 mN at 30 mM (n 17), 273 AE 93 mN at 40 mM (n 12) and 322 AE 68 mN at 60 mM K (n 8). In all DF 2 experiments, 30 mM K , which induced moderate contractures, was used to avoid fatigue of the muscle frequently observed during repeated K application, particularly at higher concentrations. As shown for a representative experiment in Fig. 5C 100 nM DF 2 increased the amplitude of the K -induced contracture by 86% from 165 mN in the control to 307 mN with the peptide. The potentiating effect was reversed within 15 min by washing. Although present and reversible in successive peptide applications, the DF 2 effect tended to decline during repeated measurements in a given experiment. Therefore, to obtain a dose response curve for the effect of DF 2 on K contractures (Fig. 5D) , each peptide concentration was applied only once to a given preparation. DF 2 potentiation of tension development was dose-dependent. The threshold for a signi®cant increase in contracture amplitude was between 0.1 and 1 nM, the EC 50 value was at 40 nM, i.e. at similar concentrations as reported for neuromuscular effects by other FaRPs in crustaceans (Mercier et al., 1990; Skerrett et al., 1995; Worden et al., 1995; Jorge-Rivera & Marder, 1996) . Although peptide concentrations above 1 mM were not tested, the data suggest that the maximally effective concentration is around 1 mM with an average increase in the amplitude of K evoked contractures by 122 AE 28% (n 4).
Effects of DF 2 on contractions in current-clamped fibres
As shown previously, in current-and voltage-clamp experiments graded contractions develop in these ®bres only upon depolarization beyond the excitation-contraction (E-C) threshold. This potential coincides with the activation threshold of the high voltage-activated inward Ca 2 current at approximately À40 mV. Tension development is positively correlated with this current (Weiss et al., 2001) . In current-clamp experiments, application of 100 nM DF 2 produced a strong increase in peak tension. For most ®bres (nine of 13), electrical membrane responses remained graded upon addition of DF 2 . However, in four of the ®bres that responded with graded electrical activity under control conditions (Fig. 6A) , application of DF 2 induced all-or-nothing action potentials (Fig. 6B) . The plot of peak tension amplitude (T peak ) as a function of applied current quantitatively shows the potentiation of contraction by the peptide for a typical experiment (Fig. 6C) . A plot of T peak against membrane potential (Fig. 6D) shows that contractions develop only upon depolarizations beyond E-C threshold (approximately À38 mV) in controls and in the presence of DF 2 . Regardless of the type of DF 2 effects on electrical membrane responses, we never observed a signi®cant change in E-C threshold with the peptide. In current-and voltage-clamped ®bres, a sharp voltage threshold exists for the initiation of contractions (EC-threshold), which coincides with the voltage threshold for activation of the I Ca . This is in contrast to the observation that depolarizations evoked by elevated K elicit contractures already at membrane potentials more negative than the threshold found in voltage-and current-clamp experiments.
As was the case with peak tension amplitude under control conditions, the DF 2 -induced potentiation of contraction varied considerably among preparations (Fig. 7A ) but was present in all experiments. Pooling of data shows a 26-fold increase in peak tension amplitude by the peptide used at a concentration of 100 nM (P 0.01, n 13, Fig. 7B ).
DF 2 effects on inward Ca 2 current in voltage-clamped fibres
Isolated high-voltage-activated inward currents were measured under two-electrode voltage-clamp condition using the K channel blocker TEA and 4-AP to suppress the outward current normally masking the inward current in Idotea extensor muscle ®bres (Weiss et al., 2001) . As previously shown on the single channel level (Erxleben & Rathmayer, 1997) , the inward current is carried by Ca 2 entry through dihydropyridine-sensitive L-type channels. As the density of Ca 2 currents varies greatly and larger currents can be recorded in Idotea muscle ®bres with Ba 2 or Sr 2 as charge carrier (Weiss et al., 2001) , Ca 2 was replaced by Ba 2 . Application of 500 nM DF 2 markedly enhanced the inward current (Fig. 8A) . The peptide potentiated the peak and the integrated current over the range of stepping potentials investigated ( Fig. 8B and C) . Enhancement of the depolarization-activated inward currents was observed in two other ®bres. On average, peak current was signi®cantly potentiated by DF 2 to 225 AE 46%, the integrated current to 244 AE 43% of the controls (P 0.03, n 3, Fig. 8D and E) . . Only the fourth current pulse elicited a small contraction. (B) Application of 100 nM DF 2 depolarized the ®bre from À77 to À67 mV and decreased R i from 327 to 266 kO. The graded electrical membrane response was converted into all-ornothing action potentials accompanied by a large contraction. (C) Peak tension amplitude (T peak ) which occurs with a small delay after the end of the current pulses, is plotted as a function of applied current. (D) Peak tension amplitude (T peak ) related to membrane potential (V m ), which was determined at the end of the current pulses. E-C threshold of this ®bre was at À38 mV, and was not changed by the peptide. 
Discussion
Localization of FaRPs in efferent neurons
In this study, immunoreactivity was detected using a polyclonal antiserum raised against the synthetic tetrapeptide FMRFamide. As no FaRPs have been sequenced in isopods so far, the peptide(s) stained in Idotea are considered to belong to the group sharing the C-terminal sequence XLRFamide (with X standing for F or R), which includes DF 2 and is widespread among crustaceans Krajniak, 1991; Mercier et al., 1993; Weimann et al., 1993; Sithigorngul et al., 1998 Sithigorngul et al., , 2001 Sithigorngul et al., , 2002 .
FMRFa immunoreactivity was found in various interneurons, but most prominently in a single pair of efferent neurons in pereion ganglion 5. With their speci®c size and topography, the two FMRFair neurons match homologous pairs of efferent neurons present in all pereion ganglia. They have been shown to be proctolin-immunoreactive in peg 4, and allatostatin-immunoreactive in all other pereion ganglia. The present ®ndings suggest colocalization of a FMRFamide and allatostatin in the pair of neurons in peg 5. This assumption is supported by ongoing studies employing antibodies marked with immunogold against allatostatin and FMRFamide (S. Kreissl, Utz & W. Rathmayer, unpublished results) . Proctolin exerts excitatory modulation, whereas allatostatin is an inhibitory modulator of neuromuscular parameters (Kreissl et al., 1999; Bru Èstle et al., 2001; Rathmayer et al., 2002b) . The functional implications of colocalization of two peptides, which exert antagonistic modulation of the same pre-and post-synaptic neuromuscular parameters by converging actions on the same targets deserves further study.
The FMRFa-ir axons of the two neurons in peg 5 project ipsilaterally through nerves N3 into the ventral sinus nerve and the dorsal lateral nerve (DLN) running on both sides of the animal from head to telson. The axon in the sinus nerve forms numerous varicose endings closely attached to¯exor muscle ®bres of all segments, that in the DLN forms varicosities on parts of the two-segmental extensor muscle ®bres of posterior segments only and in the pericardial organ. FMRFa immunoreactivity is absent on the one-segmental ®bres of the extensor muscle. This situation resembles that in various leg muscles of the cockroach, where FMRFa-ir axons contact only some of the muscle ®bres (Elia & Orchard, 1995) . Without electron microscopical studies one must be cautious in interpreting the varicosities in the DLN as neuromuscular synapses, which deliver the modulatory peptides directly onto the target where the nerve is in contact with muscle ®bres. However, muscle ®bres can be supplied with modulators from sources other than neuromuscular synapses. According to Delaleu (1970) , the DLN in oniscoidean crustaceans is formed by axons coming from the segmental nerves N3 in all postantennal segments. It forms anteriorly the lateral cephalic plexus, and posteriorly the pericardial organ. Both structures function as neurohaemal organs (Chaigneau, 1983) . In Idotea, each DLN and the pericardial organs contain FMRFa-ir, allatostatin-ir and proctolin-ir axons coming from homologous pairs of efferent neurons. In addition to the more direct supply by the varicosities on the muscle, the modulators are most likely released from the pericardial organs into the haemolymph and distributed to all extensor muscle ®bres and other target muscles.
Targets of the modulation and potentiation of contractions by FaRPs
Potentiation of neuronally evoked muscle contractions by FaRPs including DF 2 has been described in crab, lobster and cray®sh. The peptides act mainly presynaptically by increasing transmitter release at neuromuscular junctions (Mercier et al., 1990; Pasztor & Golas, 1993; Skerrett et al., 1995; Worden et al., 1995; Jorge-Rivera & Marder, 1996; Friedrich et al., 1998) . The increase of EPSC amplitude observed in the present study is most likely due to the same presynaptic effects, i.e. an increase in the number of transmitter quanta released by the action potentials invading the neuromuscular terminals. It was shown recently that the presynaptic enhancement of transmitter output by DF 2 at crab neuromuscular junctions is caused by the modulation of oconotoxin-sensitive Ca 2 channels which pharmacologically resemble vertebrate N-type channels, but not of o-agatoxin-sensitive channels which resemble vertebrate P/Q-type Ca 2 channels (Rathmayer et al., 2002a) . As the endings of the slow excitatory axon lack N-type Ca 2 channels, modulation by DF 2 is restricted to the junctions of the fast axon that is endowed with P/Q-and N-type channels. However, in neurons of Aplysia and of the pond snail Helisoma, FaRPs cause a presynaptic inhibition of transmitter release by reducing both Ca 2 in¯ux into the terminals and the effectiveness of Ca 2 on the secretory machinery (Man-Son-Hing et al., 1989; Haydon et al., 1991; Cropper et al., 1994) . In some molluscan neurons, FMRFamide exerts two effects by activating different currents. One effect is a slow response caused by activating nonvoltage-dependent K and partially suppressing Ca 2 conductance, both of which involve G-protein-coupled signalling (Cottrell et al., 1984; Brezina et al., 1987a,b; Green et al., 1994; Lesser et al., 1997) . Another effect of FMRFamide is the direct gating of an amiloride-sensitive channel with a high selectivity for Na over K and divalent ions without involvement of Gproteins, which results in a rapid depolarization (Ruben et al., 1986; Green et al., 1994; Cottrell, 1997) .
In Idotea, the presynaptic effect of DF 2 on transmitter release was always accompanied by postsynaptic effects at the muscle membrane. The observed depolarization of the extensor muscle ®bres by the peptide is in accord with ®ndings in shrimp stomach muscle (Meyrand & Marder, 1991) but is in contrast to our observations in the closer muscle of the crab Eriphia, as well as of other crustaceans where three FaRPs including DF 2 did not change membrane potential or input resistance of muscle ®bres (Mercier et al., 1990; Skerrett et al., 1995; Worden et al., 1995; Jorge-Rivera & Marder, 1996) . The fact that FaRPs exert different, sometimes opposing effects in different species, is further substantiated by ®ndings that other FaRPs than those just mentioned even cause a slight increase in input resistance in muscles, e.g. of lobster, shrimp and cray®sh (Mercier et al., 1990; Meyrand & Marder, 1991; Skerrett et al., 1995) .
Also in muscles of noncrustaceans, the effects of different FaRPs vary and show opposite effects. YGGFMRFamide reduces resting K conductance of extensor tibiae muscle ®bres of the locust (Walther et al., 1998) . However, in another muscle of the same species, the insect FaRP SchistoFLRFamide, ManducaFLRFamide and leucomyosuppressin induce hyperpolarization (Lange & Cheung, 1999) . FMRFamide-activated K currents have been found in radula muscles of Aplysia (Cropper et al., 1994; Scott et al., 1997) . In heart muscle cells of the snail Lymnaea, FMRFamide activates a cobalt-sensitive cation-conducting channel that normally carries Ca 2 but in the absence of Ca 2 admits Na and also Ba 2 , even at the cells resting potential (Brezden et al., 1991) . Variability of the neuromuscular effects of different FaRPs in the same species, but also of identical peptides in different species have been observed frequently and may re¯ect differences among the receptors and targets of intracellular signalling pathways. In Idotea, the depolarization of muscle ®bres and the decrease of membrane resistance were blocked when Co 2 substituted Ca 2 but were insensitive to amiloride and nifedipine. These effects are thus unlikely due to the directly peptide-gated Na current known from snail neurons but suggest the participation of nifedipineinsensitive nonL-type Ca 2 currents. It has to remain open at present whether the current responsible for the depolarization is carried exclusively by Ca 2 or whether Ca 2 just sensitizes another inward current. This has been shown to be the case in the depolarization exerted by the peptides proctolin and a FMRFamide in crustacean stomatogastric neurons (Golowasch & Marder, 1992; Swensen & Marder, 2000) . In these preparations, however, the effect of Ca 2 is opposite to that observed in Idotea muscles because substituting Ca 2 with Co 2 increased the inward current. If a Ca 2 current, activated by DF 2 , plays a sensitizing role for additional inward currents, this would explain why we never observed contractions accompanying the depolarizations. The Ca 2 entry could just be too small for triggering the Ca 2 -induced Ca 2 release from the sarcoplasmatic reticulum, which is essential for tension generation in these ®bres (Weiss et al., 2001) .
The potentiation of K contractures in the absence of neuronal activity upon application of DF 2 has been observed also in other crustacean preparations (Worden et al., 1995; Jorge-Rivera & Marder, 1996) . Whereas in voltage-clamped ®bres, the E-C threshold is quite narrow at À38 AE 1 mV and identical with the activation threshold for the high voltage-activated inward Ca 2 current (Weiss et al., 2001 ), K contractures already develop at much smaller depolarizations starting from membrane potentials of approximately À60 mV. One possible explanation for this discrepancy is the presence of slowly activating, nonL-type Ca 2 channels. Their modulation by DF 2 could explain the potentiation of K contractures at small depolarizations. The described pre-and postsynaptic excitatory effects of DF 2 and the presence of a pair of FMRFamide-immunoreactive efferent neurons suggest an involvement of a FMRFamide-related peptide in the modulation of muscle contraction in Idotea. In vivo, this peptide should increase the ef®cacy of motor input to muscles and result in the potentiation of muscle performance.
